Call for Submissions
Harm Reduction Journal. Topic: Indigenous communities and harm reduction. Deadline: September 2026.
Spotlight
Kolla, G., et al. 2026. Reduced risk of overdose among clients of a safer opioid supply program in Southwestern Ontario: A pre-post observational cohort study. IJDP.
A study of a safer opioid supply (SOS) program in Kitchener-Waterloo found large reductions in non-fatal overdose in the six months after enrollment. Among 100 participants who completed follow-up, overdose prevalence dropped from 60% at program entry to 15% at six months, with overdose rates falling from 48.5 to 3.3 per 100 person-months. After accounting for factors such as homelessness, hospitalization, daily fentanyl use, and incarceration, participants had 83% lower odds of experiencing a non-fatal overdose. These findings suggest safer supply programs can substantially reduce overdose risk among people at highest risk in the current toxic drug supply.
Recent publications
Perri, M., et al. 2026. Defining success together: a collaborative approach for client and provider-engaged outcomes indicator development in Ontario
Mihic, T., et al. 2025. Community Pharmacy‐Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program
McDermid, J., et al. 2026. “I Know So Many Women That Have the Same Story as Mine”: Exploring How the Increase of Benzodiazepines in the Unregulated Drug Supply Shapes Experiences of Gender-Based Violence Among Women and Gender Minorities in Vancouver
Do, U., et al. 2026. A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
McAdam, E., et al. 2025. Policing and access to harm reduction services among young people who use drugs and young Indigenous people who use drugs before and after the pilot implementation of decriminalization of personal possession
Hawke, L., et al. 2026.Writing Patient Engagement Effectively Into Grant Applications: Practical Tips for Grant Writers
Panagiotoglou, D., et al. 2025. Toronto’s Supervised Consumption Sites and Local Crime
Ledlie, S., et al. 2026. Trends in fentanyl-containing drug samples seized by law enforcement agencies across Canada
Hamzat, B., et al. 2026. Opioid dispensing prior to opioid toxicity hospitalizations and emergency department visits in Canada, 2018–2022
ODPRN. 2025. Evolving extended-release subcutaneous buprenorphine (BUP-ER; Sublocade®) treatment patterns in Ontario
Sibley, A.L., et al. 2025. A brick to a bundle: a qualitative study of behavioural responses to xylazine adulteration
Latkin, C.A., et al. 2026. Perceptions and Experiences of Xylazine, Disparities in Xylazine Awareness, and Correlates of Xylazine-Attributed Wounds Among People Who Use Opioids
Hill, K., et al. 2026. “Everybody’s Liking It”—Intentional Use of Xylazine in Fentanyl Among People Who Use Drugs
MedPage Today. Gabapentin Under Scrutiny: 2025 Data Challenged Risk Profile — New research questioned old assumptions
Cerceo, E., et al. 2026. Disaster Within a Disaster: Ensuring Access to Opioid Use Disorder Treatment During Natural Crises
Ashton, K., et al. 2026. Safer inhalation devices: a rapid Health Impact Assessment of a harm reduction pilot for people who smoke crack cocaine
Eldridge, LA., et al. 2026. Expanding access to harm reduction in rural communities through community-informed public health vending machines
Bailey, E.J., et al. 2026. “Because we’re the experts”: centering the expertise of people who use drugs to identify and propose solutions for overdose prevention
Houborg, E., et al. 2026. Between decriminalization policy and police practice: Implementation of warnings for marginalized people dependent on drugs in Denmark
Singh, et al. 2026. Juvenile crimes and drugs: A review of structural and psychosocial determinants in the context of drug decriminalization
Iacobelli, N.P., et al. 2026. “You’re doing it because your freedom is on the line”: a qualitative study exploring how people who use opioids and methamphetamine navigate legal involvement and carceral treatment for substance use disorder
Sheinin, J., et al. 2026. Cocaine Use, Unhealthy Alcohol Use, and Pain Interference Among People with HIV
Willing, A.R., et al. 2026. Service provider perceptions of incorporating hepatitis C testing technologies into standard practice: Considerations for widespread implementation and scale-up
Berk, J., et al. 2026. Hepatitis C treatment in a jail setting: A retrospective cohort analysis of low-barrier initiation of direct acting antivirals.
Smith, J.J., et al. 2026. Potential health impacts of comprehensive access to opioid use disorder treatment in United States correctional facilities: A synthetic analysis
Chambers, L.C., et al. 2026. Risk of opioid overdose during buprenorphine treatment for opioid use disorder in the fentanyl era
Sonoma, et al. 2025. Practical guidance for navigating buprenorphine discontinuation
Goutham, S., et al. 2026. Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial
Fischer, B., et al. 2026. Strategic approaches to reducing the substance use-related burden of disease in Canada
Cahn, A., et al. 2026. Summary of: Clinician Experiences and Comfort with Providing Harm Reduction Resources to People Who Use Drugs
Seear, K. 2026. Drug law is a multi-species concern.
